Hopo Therapeutics
UEI: H5MWN5ZBXQ98
• CAGE: 8L3L6
Overview
Parent Awardee
Name
Hopo Therapeutics
Website
Headquarters
Berkeley, CA
United States
United States
Most Recent Award
Sept. 30, 2024
Calculating
Federal contract recipient
HOPO THERAPEUTICS, INC.
(UEI H5MWN5ZBXQ98, CAGE 8L3L6)
is headquartered in Berkeley CA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in February 2020 and
federally registered in
September 2024.
Federal Award Analysis
Hopo Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
HOPO THERAPEUTICS, INC.
UEI
H5MWN5ZBXQ98
CAGE Code
8L3L6
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Feb. 27, 2020
Initial Registration
Sept. 20, 2024
Last Registration
Sept. 26, 2024
Registration Activation
Sept. 23, 2024
Registration Expiration
Sept. 20, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Disaster Registry
Specific Regions
Reported NAICS
Accepts Credit Cards
No